相关实验视频
Updated: May 10, 2025

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.7K
多克索鲁比介导性心脏毒性的病理生理学
Roberto Arrigoni1, Emilio Jirillo2, Carlo Caiati3
1Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM), National Research Council, 70124 Bari, Italy.
Toxics
|April 25, 2025
概括
多克索鲁比 (DOX) 化疗通过多种途径引起心脏损伤 (心脏毒性). 恢复SIRT 1水平可能是缓解这种严重副作用的治疗策略.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学 是一个学科.
背景情况:
- 多克索鲁比 (DOX) 是各种癌症的重要化疗剂.
- DOX诱导的心脏毒性 (DIC) 是一种严重的剂量限制副作用,导致心力衰竭.
- DIC涉及通过核和线粒体通路的心肌细胞死亡,由氧化应激,炎症和亡/铁亡驱动.
研究的目的:
- 审查多克索鲁比诱导心脏毒性 (DIC) 的病理生理学.
- 确定缓解DIC的潜在治疗目标.
- 探索DIC的新兴治疗策略.
主要方法:
- 对多克索鲁比诱导心脏毒性研究的文献综述.
- 分析病原遗传机制,包括氧化应激,自和亡/亡.
- 关于Sirtuins (SIRT),特别是SIRT 1在DIC中的作用的研究.
主要成果:
- 在DIC模型中观察到SIRT 1水平降低,并导致心脏损伤.
- SIRT 1通过抑制活性氧物种和NF-kB激活起着保护作用.
- 自然产品 (多),纳米配方和铁化剂在DIC模型中显示出潜力.
结论:
- 恢复SIRT 1水平为DIC提供了一个有希望的治疗策略.
- 需要进行进一步的临床试验,以验证新型化合物和DIC策略的疗效.
- 了解DIC病理生理学对于开发有效的心脏保护干预措施至关重要.
相关概念视频
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Heart Failure Drugs: Inotropic Agents
405
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
405
Pathophysiology of Cardiac Performance
486
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
486
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305
Imbalances in Cardiac Output
1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.2K
Electron Transport Chain: Complex I and II
9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.6K

